Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

about

Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.

P2860

Q33777950-3EC4E80F-32E9-439B-93D6-12B68E2EDB72

P2860

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

Item

http://www.wikidata.org/entity/Q40502992

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

@en

type

Item

label

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

@en

prefLabel

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

@en

P1476

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

@en

P2093

David J Gasper

http://www.w3.org/2001/XMLSchema#string

Lauren A Trepanier

http://www.w3.org/2001/XMLSchema#string

Yat Yee Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells

Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo

HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.

Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection.

Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.

Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.

P304

10-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TOX.2016.08.010

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

368-369

http://www.w3.org/2001/XMLSchema#string

P50

Thomas C. Friedrich

Eva G Rakasz

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27565715

http://www.w3.org/2001/XMLSchema#string

P932

5069186

http://www.w3.org/2001/XMLSchema#string

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

about

P2860

P2860

Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932